Anthony Fauci, director of the National Institute of Allergy and Infectious Disease said that scientists at the National Institutes of Health (NIH) would partner with the Liberian government to launch a clinical trial of two vaccines.
The Sierra Leone government will work with researchers at the Centers for Disease Control and Prevention to test one of the vaccines.
An effective Ebola vaccine could help to control the current outbreak and could be lifesaving in future outbreaks.
Beyond vaccines, NIH doctors will work with Liberia to test the experimental treatment drug Zmapp. The drug has been given to several Ebola patients but has never been formally tested in humans, officials say. The studies will be conducted in the USA and Liberia.
According to the World Health Organization, Ebola has infected 21,759 people and killed 8,668, primarily in Guinea, Liberia and Sierra Leone.
- » News Central
- » Popular News
- » Latest Health News
- » News Category A-Z (500+)
- » Health News and Press Release
- » News Archive
- » News Photo Gallery
- » Lifestyle and Wellness
- » Health Watch
- » Health In Focus
- » Celebrating Life
- » Breaking Health News
- » News From Other Resources
- » India Special
- » News Video Gallery
- » Medindia Exclusive - Interviews and In depth Reports